← Open Payments lookup

DEBORAH SHELDON: Open Payments

NPI 1649538448 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$374 in 19 payments from 12 companies in 2025. Trend: 2023 $300 · 2024 $609 · 2025 $374

Food & beverage: $374
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.3$63
Genentech USA, Inc.2$51
ARGENX US, INC.2$46
Fresenius USA Marketing, Inc.2$35
Vifor Pharma, Inc.2$34
Takeda Pharmaceuticals U.S.A., Inc.1$33
Travere Therapeutics, Inc.2$25
Teva Pharmaceuticals USA, Inc.1$19
Phathom Pharmaceuticals, Inc.1$19
Janssen Biotech, Inc.1$18

Products named: Kerendia, Ocrevus Zunovo, VELPHORO, Veltassa, EOHILIA, AUSTEDO XR, VOQUEZNA, TREMFYA.

Industry payments across NE — which companies pay providers there.